Translating the promise of 5HT4 receptor agonists for the treatment of depression
Animal experimental studies suggest that 5-HT4 receptor activation holds promise as a novel target for the treatment of depression and cognitive impairment. 5-HT4 receptors are post-synaptic receptors that are located in striatal and limbic areas known to be involved in cognition and mood. Consisten...
Үндсэн зохиолчид: | Murphy, SE, de Cates, AN, Gillespie, AL, Godlewska, BR, Scaife, JC, Wright, LC, Cowen, PJ, Harmer, CJ |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Cambridge University Press
2020
|
Ижил төстэй зүйлс
-
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
-н: de Cates, AN, зэрэг
Хэвлэсэн: (2024) -
Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task
-н: de Cates, AN, зэрэг
Хэвлэсэн: (2021) -
5-HT4 receptor agonist effects on functional connectivity in the human brain: implications for procognitive action
-н: de Cates, AN, зэрэг
Хэвлэсэн: (2023) -
The effect of the 5-HT4 agonist, Prucalopride, on a functional magnetic resonance imaging faces task in the healthy human brain
-н: de Cates, AN, зэрэг
Хэвлэсэн: (2022) -
The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
-н: Smith, ALW, зэрэг
Хэвлэсэн: (2023)